-
Two important papers!
Time of Update: 2022-04-28
▲Compared with the current control group, as the severity of the disease in the acute phase of new coronary infection increased, the risk of new-onset diabetes, the risk of needing hypoglycemic drugs, and the risk of the composite outcome of the two also increased significantly .
-
PNAS Li Da of China Medical University / Huang Yingqun of Yale University Uncover a New Approach to Metformin Drug Hypoglycemic
Time of Update: 2022-04-28
iNature metformin, as a first-line antidiabetic drug, has received increasing attention in the prevention and treatment of aging, cancer and cardiovascular disease . However, a clear mechanistic und
-
"Talking about sugar control with internal and external training" is at hand, where is the sword pointing - how to help patients better optimize the initial treatment of basal insulin?
Time of Update: 2022-04-28
The case of Professor Yang Zhixia from Langfang People's Hospital: The case mentioned in this issue is a middle-aged woman with type 2 diabetes mellitus with poor blood sugar control for 14 years and was admitted to hospital for treatment.
-
"2 mg/week", FDA approves larger dose of "semaglutide" for diabetes treatment
Time of Update: 2022-04-28
S. Food and Drug Administration recently approved a larger-strength (2 mg/week) weekly formulation of the GLP-1 receptor agonist semaglutide (Ozempic, Novo Nordisk) for adults with type 2 diabetes treatment .
FDA Okays Semaglutide Higher Dose, 2 mg/Week, for Type 2 Diabetes[EB/OL].
-
NEJM evidence-based: a new subtype of type 2 diabetes?
Time of Update: 2022-04-28
The clinical features found that they were generally not obese, had good beta-cell insulin secretion and even better insulin sensitivity, but had lower insulin levels and higher fasting blood glucose .
-
The only new basal insulin analog on the list!
Time of Update: 2022-04-28
Figure 2 CONFIRM study results Poor blood sugar control will bring long-term complications and increased risk of death, which will further increase the health and economic burden of patients [8] .
Summary Taking efficacy, safety, and cost-effectiveness as the consideration criteria, WHO will include long-acting insulin analogs in EML in 2021 .
-
How to prevent osteoporosis with long-term application of "hormones"?
Time of Update: 2022-04-28
According to the "2020 Edition of Chinese Expert Consensus on the Prevention and Treatment of Glucocorticoid-induced Osteoporosis" [3], in the initial treatment of GIOP, those with low fracture risk are recommended to adjust their life>etc.
-
If you have diabetes, do you only look at your blood sugar?
Time of Update: 2022-04-28
*For medical professionals to read and reference In diabetes management, most patients only focus on blood sugar levels, but do you understand these complications?
Under the combined effects of metabolic syndromes such as hyperglycemia, obesity, and hypertension, the rate of atherosclerosis in diabetic patients is much faster than that in normal blood sugar [6] .
-
The latest international "Position Statement on Prolactin-secreting Tumors" was released, compiled and shared by Professor Li Wangen's team
Time of Update: 2022-04-28
It is recommended not to discontinue dopamine agonists in patients with large prolactinoma who have been receiving long-term dopamine agonist therapy if the tumor has not shrunk significantly or the PRL level cannot be reduced to normal (LoA 9) .
-
"Nature": The mechanism that obesity "destroys" immunity has been found!
Time of Update: 2022-04-28
There are many clinical studies showing that for a variety of immune inflammatory diseases, including atopic dermatitis and asthma, obese patients have relatively more severe symptoms and show resistance to treatments that are effective in normal-weight patients, but the potential The mechanism is not clear [2] .
-
Ten questions and ten answers: One article to grasp the clinical application of DPP-4i
Time of Update: 2022-04-27
Combined with the newly released "Expert Guidance and Suggestions on Common Problems in Clinical Application of Dipeptidyl Peptidase 4 Inhibitor in Primary Medical Institutions", This article summarizes ten problems that may be encountered in the clinical use of DPP-4i for teachers' reference .
-
The Lancet: After contracting the new crown, the risk of diabetes increases, even in patients with mild symptoms
Time of Update: 2022-04-27
People infected with Covid-19 had a nearly 40 percent higher risk of developing diabetes a year later than those in a control group who didn't have Covid-19 .
-
How to treat different types of hyperglycemia?
Time of Update: 2022-04-27
Medication countermeasures: In order to effectively control the dawn phenomenon, that is, high blood sugar on an empty stomach in the morning, oral hypoglycemic drugs with a longer half-life can be taken orally before going to bed .
-
Wei Mi group is virtuous and thinks flying, helping Jun Qingtian to embrace the bright moon - a review of hot topics in the endocrine field of "Vi Mi Club"
Time of Update: 2022-04-27
On the fourth day of the conference to further explore the standardized management plan of childhood obesity, Professor Gong Chunxiu from Beijing Children's Hospital Affiliated to Capital Medical University introduced the clinical differential diagnosis of different diseases that cause obesity, and shared different prevention and treatment plans.
-
Seven categories of drugs can cause "thyroid disease", how to correctly identify and deal with it?
Time of Update: 2022-04-27
A variety of drugs can cause changes in different types of thyroid hormones, resulting in mild thyroid dysfunction, but common drugs that cause clinically significant thyroid disease are as follows: ➤Interferon alpha; ➤Iodine preparations, such as amiodine Ketones, iodophors; ➤ lithium salts; ➤ hormones, such as corticosteroids, estrogens; ➤ non-steroidal anti-inflammatory drugs; ➤ beta-adrenoceptor blockers; Wait .
-
Comprehensive analysis of CT differential diagnosis of common thyroid nodules
Time of Update: 2022-04-27
*For medical professionals to read the CT imaging manifestations of thyroid nodules for reference Its published content is accurate and reliable when it is reviewed and approved, but it does not make
-
Diabetic Nonketotic Hyperosmolar Syndrome: How Much Fluid and When to Change Salt Water to Sugar Water?
Time of Update: 2022-04-27
2. Condition observation strengthens the intervention of the disease, tilts the patient's head to one side, always pays attention to the patency of the indwelling gastric tube, regularly injects warm water to replenish the lost fluid, reduces the hyperosmolar situation, and controls the insulin drip in combination with the patient's blood sugar concentration If the patient develops shock or heart failure, monitor pupillary changes and consciousness .
-
The guidelines say that patients with osteoporosis should exercise like this!
Time of Update: 2022-04-27
As a result, many osteoporosis patients have weakened exercise ability due to bone pain and decreased muscle strength, and even have osteoporotic fractures, and they no longer dare to try sports .
-
6 points, 2 programs, quickly teach your diabetics how to self-regulate insulin
Time of Update: 2022-04-27
According to the patient's blood sugar, the insulin dose before breakfast and dinner was increased by 2 units (ie 18U in the morning and 10U in the evening) .
-
Diabetic patients can't lower their urine protein, what's wrong?
Time of Update: 2022-04-26
Among the patients with diabetic nephropathy treated, it is basically in the early stage, so that the secondary nephrotic syndrome is ignored when encountering a large amount of urine protein .